Global HER2 Testing Market Growth 2023-2029

Global HER2 Testing Market Growth 2023-2029

The global HER2 Testing market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for HER2 Testing is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for HER2 Testing is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for HER2 Testing is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key HER2 Testing players cover Abbott, Hoffmann-La Roche Ltd, Agilent Technologies, Inc., Thermo Fisher Scientific, Inc., Leica Biosystems (Danaher Corporation), Empire Genomics, Inc. (Biocare Medical, LLC), Bio-Genex Laboratories, Abnova Corporation and Oxford Gene Technology IP Limited (Sysmex Corporation), etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

LPI (LP Information)' newest research report, the “HER2 Testing Industry Forecast” looks at past sales and reviews total world HER2 Testing sales in 2022, providing a comprehensive analysis by region and market sector of projected HER2 Testing sales for 2023 through 2029. With HER2 Testing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world HER2 Testing industry.

This Insight Report provides a comprehensive analysis of the global HER2 Testing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on HER2 Testing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global HER2 Testing market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for HER2 Testing and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global HER2 Testing.

This report presents a comprehensive overview, market shares, and growth opportunities of HER2 Testing market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type
Fluorescence In Situ Hybridization
Dual-Probe
Single-Probe
Chromogenic In Situ Hybridization (CISH)
Silver-Enhanced In Situ Hybridization

Segmentation by application
Hospitals
Diagnostic Laboratories
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Abbott
Hoffmann-La Roche Ltd
Agilent Technologies, Inc.
Thermo Fisher Scientific, Inc.
Leica Biosystems (Danaher Corporation)
Empire Genomics, Inc. (Biocare Medical, LLC)
Bio-Genex Laboratories
Abnova Corporation
Oxford Gene Technology IP Limited (Sysmex Corporation)

Key Questions Addressed in this Report

What is the 10-year outlook for the global HER2 Testing market?

What factors are driving HER2 Testing market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do HER2 Testing market opportunities vary by end market size?

How does HER2 Testing break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.